Biotest Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Biotest has a total shareholder equity of €535.9M and total debt of €566.8M, which brings its debt-to-equity ratio to 105.8%. Its total assets and total liabilities are €1.4B and €839.9M respectively. Biotest's EBIT is €175.4M making its interest coverage ratio 5. It has cash and short-term investments of €66.3M.
Belangrijke informatie
105.8%
Verhouding schuld/eigen vermogen
€566.80m
Schuld
| Rente dekkingsratio | 5x |
| Contant | €66.30m |
| Aandelen | €535.90m |
| Totaal verplichtingen | €839.90m |
| Totaal activa | €1.38b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 000325670's short term assets (€738.9M) exceed its short term liabilities (€301.2M).
Langlopende schulden: 000325670's short term assets (€738.9M) exceed its long term liabilities (€538.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 000325670's net debt to equity ratio (93.4%) is considered high.
Schuld verminderen: 000325670's debt to equity ratio has increased from 67.7% to 105.8% over the past 5 years.
Schuldendekking: 000325670's debt is well covered by operating cash flow (21%).
Rentedekking: 000325670's interest payments on its debt are well covered by EBIT (5x coverage).